Precision Therapeutics raises $33 million in Series D financing

06/14/2010 | American City Business Journals

Precision Therapeutics secured $33 million in a Series D funding round, led by venture capital firm Bain Capital. Precision will use the proceeds to boost the growth of ChemoFx, a technology that helps identify a type of chemotherapy that is likely to benefit an individual cancer patient, and develop genomics-based products.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ